In a subsequent investigation, Zhang et al. elucidated the role of epidermal growth factor, a known contributor to prostate cancer progression, in inducing EMT by negatively modulating EPLIN expression via ERK1/2 activation. The gene discussed is MAPK3; the disease is prostate carcinoma.